Genome Engineering Future

Genome engineering technologies is the synthetic assembly of complete chromosomal DNA based on synthetic nucleases and transcription factors enable the targeted modification of the sequence and expression of genes. Recent advances in genome engineering technology such as CRISPR-Cas9 have brought it to the forefront, making it a highly discussed topic in both scientific and mainstream worlds. Editing DNA can lead to changes in physical traits, like eye color, and disease risk. Scientists use different technologies to do this. The main aim of the journal is to address the advances in genome and epigenome editing technologies and their implications in research and clinical translation.

High Impact List of Articles

Conference Proceedings

Chromatin structure and chromosomal rearrangements in CD34+ cells and lymphocytes from Myelodysplastic syndromes (MDS) patients
Martin Falk
Keynote: Molecular and Genetic Medicine
Chromatin structure and chromosomal rearrangements in CD34+ cells and lymphocytes from Myelodysplastic syndromes (MDS) patients
Martin Falk
Keynote: Molecular and Genetic Medicine
Epigenetic biomarkers of prostate cancer - looking beyond PSA
Mithu Banerjee
Posters & Accepted Abstracts: Journal of Molecular Biomarkers & Diagnosis
Epigenetic biomarkers of prostate cancer - looking beyond PSA
Mithu Banerjee
Posters & Accepted Abstracts: Molecular Biomarkers & Diagnosis
Nanofibrous self-assembling peptide hydrogels for tissue engineering applications
Julie E. Gough
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
Nanofibrous self-assembling peptide hydrogels for tissue engineering applications
Julie E. Gough
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
� glucuronidase as an oral biomarker in the progression of periodontal disease and treatment outcomes
Afaf Zia
Posters: Journal of Tissue Science and Engineering
� glucuronidase as an oral biomarker in the progression of periodontal disease and treatment outcomes
Afaf Zia
Posters: Journal of Tissue Science and Engineering
Metabolomics of metabolic origins
Thomas Geisberger, Thomas Steiner, Wolfgang Eisenreich and Claudia Huber
Posters & Accepted Abstracts: Metabolomics:Open Access
Metabolomics of metabolic origins
Thomas Geisberger, Thomas Steiner, Wolfgang Eisenreich and Claudia Huber
Posters & Accepted Abstracts: Metabolomics:Open Access

Human Genetics & Embryology